News

The final step in the solubilization partnership between the companies is expected to aid Dow to commercially supply solubility enabling excipients. Dow senior R&D director Bob Maughon said,

According to the deal, Bristol-Myers will earn $438m upfront payment from Reckitt Benckiser for the exclusive rights to sell, distribute and market the products for a period of

Pioglitazone Tablets USP 15mg, 30mg & 45mg and Pioglitazone Hydrochloride + Metformin Hydrochloride Tablets, 15mg (base)/500mg & 15mg(base)/850mg are ready for launch. Both the products are indicated for

Uceris that contains a locally acting glucocorticosteroid, budesonide, in a novel oral tablet formulation has obtained FDA approval. Santarus research and development executive vice president Wendell Wierenga said,

The ANDA is concerned with generic version of Shire’s Adderall XR capsules, which had US sales, including brand and generic sales, of $2bn as of 31 December 2012

Under the collaboration, SCiAN will deliver a comprehensive systems and services solution for Web-based data capture and data management, including pharmacovigilance using the SAEPRO module and integrated electronic

According to the firm, the new EMERGE PC/ABS 7700 Advance Resins are PC/ABS blend, which provide a well-balanced, cost-effective solution for powered medical devices offering ignition resistance and

The agreement includes a legal framework for various collaboration projects between the two companies, covering research, development and commercialisation as well as advisory services. The financial terms of

Under the partnership, Covaris’s FS-220 GMP system and Horiba’s LA-950V2 platform will be integrated into a fully automated formulation preparation station with integrated Process Analytical Technology (PAT). The